Pacifica, CA, United States of America

Anne L Curtis

This inventor holds 2 USPTO granted patents. Top assignee: Incyte Pharmaceuticals, Inc.. Active years: 2001-2002.


% Patents Active = 50.0

Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 140(Granted Patents)


Company Filing History:


Years Active: 2001-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Anne L Curtis

Introduction: Anne L Curtis is a notable inventor based in Pacifica, CA (US). She has made significant contributions to the field of biomolecular data management, holding 2 patents that showcase her innovative approach to technology. Her work is particularly relevant in the context of modern biological research and data analysis.

Latest Patents: Among her latest patents is a system and method for a precompiled database for biomolecular sequence information. This invention involves a computer system that stores biomolecular data in a database within a memory. The biomolecular database comprises a set of entities, with each entity storing attributes for a plurality of entries. At least one attribute is stored in an array, and data associated with an entry is stored at a specific location in the array. An entity offset designates the location of the data in the array, allowing for efficient access to data associated with a particular entry for all attributes within the entity.

Career Highlights: Anne L Curtis is currently employed at Incyte Pharmaceuticals, Inc., where she continues to develop innovative solutions in the field of biomolecular research. Her expertise and contributions have positioned her as a valuable asset in her organization.

Collaborations: Throughout her career, Anne has collaborated with esteemed colleagues, including Philippe E Rigault and Richard D Goold. These partnerships have further enhanced her work and expanded the impact of her inventions.

Conclusion: Anne L Curtis exemplifies the spirit of innovation in the field of biomolecular data management. Her patents and contributions to Incyte Pharmaceuticals, Inc. reflect her dedication to advancing technology in this critical area of research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…